Vaccinia Immune Globulin (VIG) from Germany
VIG is human immune serum globulin rich in antibodies against vaccinia virus, used to manage complications from smallpox vaccination. Under HTS 3002.12.0030 as human immune blood sera from donors vaccinated with vaccinia. It provides passive immunity via intravenous or intramuscular injection.
Duty Rate — Germany → United States
15%
Rate breakdown
9903.04.6215%Patented pharmaceutical articles that are the product of Japan, of a European Union member country, of South Korea, of Switzerland, or of Liechtenstein as provided for in subdivisions (c) and (f) of U.S. note 40 to this subchapter
9903.05.860%Articles provided for in subdivision (b) of U.S. note 52 to this subchapter
Import Tips
• Include CDC emergency use authorization if applicable; standard FDA import alert 81-01 applies
• Validate heat-treated formulation docs to prove viral safety per FDA CBER guidelines